8R5R
Structure of apo TDO with a bound inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-1 |
Synchrotron site | ESRF |
Beamline | ID23-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2023-10-09 |
Detector | DECTRIS PILATUS 6M |
Wavelength(s) | 1.00 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 91.738, 132.906, 137.495 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 50.830 - 3.078 |
R-factor | 0.228 |
Rwork | 0.227 |
R-free | 0.25190 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.007 |
RMSD bond angle | 0.820 |
Data reduction software | autoPROC |
Data scaling software | autoPROC |
Phasing software | PHASER |
Refinement software | BUSTER (2.11.8) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 76.310 | 3.240 |
High resolution limit [Å] | 3.080 | 3.080 |
Rmerge | 0.171 | |
Rpim | 0.056 | |
Number of reflections | 27716 | 1386 |
<I/σ(I)> | 9.8 | 1.3 |
Completeness [%] | 95.2 | 60.6 |
Redundancy | 9.8 | 8.6 |
CC(1/2) | 0.998 | 0.536 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 293 | 5.3 mg/ml (124 uM) protein containing 2 mM AMT and 1 mM inhibitor Reservoir solution: Morpheus II condition F8 5%(w/v) PEG 20K, 25%(w/v) 1,1,1-tris(hydroxymethyl)propane, 1%(w/v) NDSB 195,0.02M of each Monosaccharide II, 0.1M BES/TEA pH 7.5 |